ABSTRACT
Management of all pathologies, and in particular that of the most frequent ones, should whenever possible be based on robust evidence and arguments. New studies published this year enable rationalizing of screening in certain clinical situations, more adequate treatment of others, and open the way for novel and apparently very effective treatments. Whether it be the screening of carotid stenosis, the treatment of pericarditis, of heart failure, of chronic obstructive lung disease or spontaneous bacterial peritonitis, paradigm changes are conceivable. This selective review of the literature summarizes certain studies published this year.
Subject(s)
Internal Medicine/trends , Adrenergic beta-Antagonists/adverse effects , Aminobutyrates/therapeutic use , Angiotensin Receptor Antagonists/therapeutic use , Asymptomatic Diseases , Atrial Fibrillation/complications , Biphenyl Compounds , Carotid Stenosis/diagnosis , Colchicine/therapeutic use , Diuretics/therapeutic use , Drug Combinations , Heart Failure/drug therapy , Hospitals , Humans , Liver Cirrhosis/complications , Narcotics/therapeutic use , Neprilysin/antagonists & inhibitors , Pericarditis/prevention & control , Peritonitis/complications , Pulmonary Disease, Chronic Obstructive/drug therapy , Pulmonary Disease, Chronic Obstructive/therapy , Respiratory Therapy , Spironolactone/therapeutic use , Stroke/etiology , Tetrazoles/therapeutic use , ValsartanABSTRACT
In an era in which primary and secondary prevention have important implications for public health and health care costs, a series of publications and guidelines give added weight or precision to current medical practice in the fields of hospital based internal medicine. This article presents a selective review of new guidelines and therapeutic options for areas of cardiovascular disease, pulmonary disease, gastroenterology and oncology.
Subject(s)
Asthma/therapy , Cardiovascular Diseases/therapy , Gastrointestinal Diseases/therapy , Humans , Internal Medicine , Neoplasms/prevention & control , Practice Guidelines as TopicABSTRACT
Numerous prospective randomised trials recently demonstrated the importance of an aggressive approach towards controlling cardiovascular risk factors. New studies reinforce the plethora of available data and confirm that interventional revascularisation strategies for stable coronary heart disease or cerebral vascular disease offer few benefits as compared to medical treatment, and can even lead to worse outcomes. This selective review describes some recent studies in the areas of cardiovascular disease, pulmonary disease, such as chronic obstructive pulmonary disease or screening of lung cancer, and gastroenterology.
Subject(s)
Cardiovascular Diseases , Gastrointestinal Diseases/drug therapy , Lung Diseases , Cardiovascular Diseases/physiopathology , Cardiovascular Diseases/prevention & control , Cardiovascular Diseases/therapy , Gastrointestinal Diseases/virology , Humans , Internal Medicine , Lung Diseases/diagnosis , Lung Diseases/drug therapy , Lung Diseases/physiopathology , Randomized Controlled Trials as Topic , Risk FactorsABSTRACT
Diabetic foot infection is a frequent, multifactorial and multifacettal disease. Its management requires an interdisciplinary collaboration. Multiple medical and surgical specialties are enrolled for its prevention and treatment, for good reasons. Concomitant management by various specialists shows a significant reduction in amputation rates. We review the issues of this interdisciplinary collaboration.
